Form 8-K - Current report:
SEC Accession No. 0001396814-18-000017
Filing Date
2018-06-15
Accepted
2018-06-15 16:17:06
Documents
1
Period of Report
2018-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K a8-kpcrx2018annualmeeting.htm 8-K 41329
  Complete submission text file 0001396814-18-000017.txt   42565
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 18902393
SIC: 2834 Pharmaceutical Preparations